Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2010 Nov 15;63(3):366–372. doi: 10.1002/acr.20405

Figure 1.

Figure 1

Annual rate of progression according to treatment status in all patients. “All” indicates a biologic treatment regardless of the use of MTX, while “+ MTX” indicates a biologic treatment together with the use of MTX. Vertical lines represent non-biologic treatment with or without DMARD treatment (0.018) and no biologic treatment with DMARD treatment (0.018).